一项随机对照试验,对采用限制碳水化合物饮食的 1 型糖尿病患者使用胰岛素与蛋白质比例的额外胰岛素注射与仅使用胰岛素与碳水化合物比例的额外胰岛素注射进行比较。

IF 2.9 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Rosemary M. Hall , Hannah J. Marshall , Amber Parry-Strong , Brian Corley , Jeremy D. Krebs
{"title":"一项随机对照试验,对采用限制碳水化合物饮食的 1 型糖尿病患者使用胰岛素与蛋白质比例的额外胰岛素注射与仅使用胰岛素与碳水化合物比例的额外胰岛素注射进行比较。","authors":"Rosemary M. Hall ,&nbsp;Hannah J. Marshall ,&nbsp;Amber Parry-Strong ,&nbsp;Brian Corley ,&nbsp;Jeremy D. Krebs","doi":"10.1016/j.jdiacomp.2024.108778","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><p>Postprandial hyperglycemia can be problematic for people with type 1 diabetes (T1DM) following carbohydrate-restricted diets. Bolus insulin calculated for meal protein plus carbohydrate may help. This study evaluated the effect of additional bolus insulin using an insulin-to-protein ratio (IPR) on glycaemic control.</p></div><div><h3>Materials and methods</h3><p>Participants with T1DM aged ≥18-years were randomly allocated (1:1) to either carbohydrate and protein-based, or carbohydrate-based insulin dosing alone for 12 weeks while following a carbohydrate-restricted diet (50-100 g/day). Measurement of HbA1c and continuous glucose monitoring occurred at baseline and 12 weeks, with assessment of participant experience at 12 weeks.</p></div><div><h3>Results</h3><p>Thirty-four participants were randomised, 22 female, mean(SD): age 39.2 years (12.6) years; diabetes duration 20.6 years (12.9); HbA1c 7.3 % (0.8), 56.7 mmol/mol (9.2). Seven in each group used insulin pump therapy. HbA1c reduced at 12 weeks with no difference between treatments: mean (SD) control 7.2 % (1.0), 55.7 mmol/mol (10.6); intervention 6.9 % (0.7), 52.3 mmol/mol (7.2) (<em>p</em> = 0.65). Using additional protein-based insulin dosing compared with carbohydrate alone, there was no difference in glycaemic variability, time spent in euglycemic range (TIR), or below range. Participants using IPR reported more control of their diabetes, but varying levels of distress.</p></div><div><h3>Conclusions</h3><p>Additional bolus insulin using an IPR did not improve glycaemic control or TIR in patients with well controlled T1DM following a carbohydrate-restricted diet. Importantly, the use of the IPR does not increase the risk of hypoglycemia and may be preferred.</p></div>","PeriodicalId":15659,"journal":{"name":"Journal of diabetes and its complications","volume":"38 7","pages":"Article 108778"},"PeriodicalIF":2.9000,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1056872724001041/pdfft?md5=13eb4814a2a0664ef5dd4c6d37fa3efd&pid=1-s2.0-S1056872724001041-main.pdf","citationCount":"0","resultStr":"{\"title\":\"A randomised controlled trial of additional bolus insulin using an insulin-to-protein ratio compared with insulin-to-carbohdrate ratio alone in people with type 1 diabetes following a carbohydrate-restricted diet\",\"authors\":\"Rosemary M. Hall ,&nbsp;Hannah J. Marshall ,&nbsp;Amber Parry-Strong ,&nbsp;Brian Corley ,&nbsp;Jeremy D. Krebs\",\"doi\":\"10.1016/j.jdiacomp.2024.108778\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aims</h3><p>Postprandial hyperglycemia can be problematic for people with type 1 diabetes (T1DM) following carbohydrate-restricted diets. Bolus insulin calculated for meal protein plus carbohydrate may help. This study evaluated the effect of additional bolus insulin using an insulin-to-protein ratio (IPR) on glycaemic control.</p></div><div><h3>Materials and methods</h3><p>Participants with T1DM aged ≥18-years were randomly allocated (1:1) to either carbohydrate and protein-based, or carbohydrate-based insulin dosing alone for 12 weeks while following a carbohydrate-restricted diet (50-100 g/day). Measurement of HbA1c and continuous glucose monitoring occurred at baseline and 12 weeks, with assessment of participant experience at 12 weeks.</p></div><div><h3>Results</h3><p>Thirty-four participants were randomised, 22 female, mean(SD): age 39.2 years (12.6) years; diabetes duration 20.6 years (12.9); HbA1c 7.3 % (0.8), 56.7 mmol/mol (9.2). Seven in each group used insulin pump therapy. HbA1c reduced at 12 weeks with no difference between treatments: mean (SD) control 7.2 % (1.0), 55.7 mmol/mol (10.6); intervention 6.9 % (0.7), 52.3 mmol/mol (7.2) (<em>p</em> = 0.65). Using additional protein-based insulin dosing compared with carbohydrate alone, there was no difference in glycaemic variability, time spent in euglycemic range (TIR), or below range. Participants using IPR reported more control of their diabetes, but varying levels of distress.</p></div><div><h3>Conclusions</h3><p>Additional bolus insulin using an IPR did not improve glycaemic control or TIR in patients with well controlled T1DM following a carbohydrate-restricted diet. Importantly, the use of the IPR does not increase the risk of hypoglycemia and may be preferred.</p></div>\",\"PeriodicalId\":15659,\"journal\":{\"name\":\"Journal of diabetes and its complications\",\"volume\":\"38 7\",\"pages\":\"Article 108778\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-05-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1056872724001041/pdfft?md5=13eb4814a2a0664ef5dd4c6d37fa3efd&pid=1-s2.0-S1056872724001041-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of diabetes and its complications\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1056872724001041\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes and its complications","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1056872724001041","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:对于限制碳水化合物饮食的 1 型糖尿病(T1DM)患者来说,餐后高血糖可能是个问题。为餐中蛋白质和碳水化合物计算的胰岛素注射可能会有所帮助。本研究评估了使用胰岛素与蛋白质比率(IPR)计算的额外胰岛素注射对血糖控制的影响:年龄≥18 岁的 T1DM 参与者被随机分配(1:1)至以碳水化合物和蛋白质为基础的胰岛素或仅以碳水化合物为基础的胰岛素剂量,为期 12 周,同时遵循碳水化合物限制饮食(50-100 克/天)。在基线和 12 周时测量 HbA1c 和连续血糖监测,并在 12 周时评估参与者的体验:34 名参与者接受了随机治疗,其中 22 人为女性,平均(标清)年龄为 39.2 岁(12.6);糖尿病病程为 20.6 年(12.9);HbA1c 为 7.3 %(0.8),56.7 mmol/mol (9.2)。每组中有 7 人使用胰岛素泵治疗。12 周后,HbA1c 有所下降,但治疗方法之间无差异:对照组平均(标度)7.2 % (1.0),55.7 mmol/mol (10.6);干预组 6.9 % (0.7),52.3 mmol/mol (7.2)(p = 0.65)。使用额外的蛋白质胰岛素剂量与仅使用碳水化合物相比,在血糖变异性、处于优血糖范围(TIR)或低于优血糖范围的时间上没有差异。使用蛋白质胰岛素的参与者报告说,他们的糖尿病得到了更好的控制,但也有不同程度的困扰:使用 IPR 额外注射胰岛素并不能改善控制良好的 T1DM 患者在碳水化合物限制饮食后的血糖控制或 TIR。重要的是,使用 IPR 不会增加低血糖风险,因此可能是首选。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A randomised controlled trial of additional bolus insulin using an insulin-to-protein ratio compared with insulin-to-carbohdrate ratio alone in people with type 1 diabetes following a carbohydrate-restricted diet

Aims

Postprandial hyperglycemia can be problematic for people with type 1 diabetes (T1DM) following carbohydrate-restricted diets. Bolus insulin calculated for meal protein plus carbohydrate may help. This study evaluated the effect of additional bolus insulin using an insulin-to-protein ratio (IPR) on glycaemic control.

Materials and methods

Participants with T1DM aged ≥18-years were randomly allocated (1:1) to either carbohydrate and protein-based, or carbohydrate-based insulin dosing alone for 12 weeks while following a carbohydrate-restricted diet (50-100 g/day). Measurement of HbA1c and continuous glucose monitoring occurred at baseline and 12 weeks, with assessment of participant experience at 12 weeks.

Results

Thirty-four participants were randomised, 22 female, mean(SD): age 39.2 years (12.6) years; diabetes duration 20.6 years (12.9); HbA1c 7.3 % (0.8), 56.7 mmol/mol (9.2). Seven in each group used insulin pump therapy. HbA1c reduced at 12 weeks with no difference between treatments: mean (SD) control 7.2 % (1.0), 55.7 mmol/mol (10.6); intervention 6.9 % (0.7), 52.3 mmol/mol (7.2) (p = 0.65). Using additional protein-based insulin dosing compared with carbohydrate alone, there was no difference in glycaemic variability, time spent in euglycemic range (TIR), or below range. Participants using IPR reported more control of their diabetes, but varying levels of distress.

Conclusions

Additional bolus insulin using an IPR did not improve glycaemic control or TIR in patients with well controlled T1DM following a carbohydrate-restricted diet. Importantly, the use of the IPR does not increase the risk of hypoglycemia and may be preferred.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of diabetes and its complications
Journal of diabetes and its complications 医学-内分泌学与代谢
CiteScore
5.90
自引率
3.30%
发文量
153
审稿时长
16 days
期刊介绍: Journal of Diabetes and Its Complications (JDC) is a journal for health care practitioners and researchers, that publishes original research about the pathogenesis, diagnosis and management of diabetes mellitus and its complications. JDC also publishes articles on physiological and molecular aspects of glucose homeostasis. The primary purpose of JDC is to act as a source of information usable by diabetes practitioners and researchers to increase their knowledge about mechanisms of diabetes and complications development, and promote better management of people with diabetes who are at risk for those complications. Manuscripts submitted to JDC can report any aspect of basic, translational or clinical research as well as epidemiology. Topics can range broadly from early prediabetes to late-stage complicated diabetes. Topics relevant to basic/translational reports include pancreatic islet dysfunction and insulin resistance, altered adipose tissue function in diabetes, altered neuronal control of glucose homeostasis and mechanisms of drug action. Topics relevant to diabetic complications include diabetic retinopathy, neuropathy and nephropathy; peripheral vascular disease and coronary heart disease; gastrointestinal disorders, renal failure and impotence; and hypertension and hyperlipidemia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信